首页> 外国专利> USE OF LOW-DOSE ERYTHROPOIETIN FOR INHIBITING STIMULATION OF ENDOTHELIAL PRECURSOR CELL, REGENERATION OF ORGAN AND PROGRESSION OF VISCERAL DISORDER

USE OF LOW-DOSE ERYTHROPOIETIN FOR INHIBITING STIMULATION OF ENDOTHELIAL PRECURSOR CELL, REGENERATION OF ORGAN AND PROGRESSION OF VISCERAL DISORDER

机译:使用低剂量的促红细胞生成素抑制内皮祖细胞的增殖,器官的再生和内脏疾病的进展

摘要

PPROBLEM TO BE SOLVED: To provide means and methods for ameliorating the stimulation of endothelial precursor cells and particularly for treating disorders associated with the dysfunctions of endothelial precursor cells, and to provide means and methods for protecting and regenerating various tissues. PSOLUTION: The treatments of diseases associated with the stimulations of the physiological mobilization, proliferation and differentiation, the stimulation of vasculogenesis and the dysfunctions of endothelial precursor cells, are provided. The uses of low-dose erythropoietin for preparing a pharmaceutical composition for treating such diseases, and such a pharmaceutical composition including: erythropoietin and other appropriate active ingredient(s) for stimulating endothelial precursor cells, are also provided. PCOPYRIGHT: (C)2011,JPO&INPIT
机译:<要解决的问题:提供改善刺激内皮前体细胞,特别是治疗与内皮前体细胞功能障碍有关的疾病的手段和方法,并提供保护和再生各种组织的手段和方法。

解决方案:提供与刺激生理动员,增殖和分化,刺激血管生成和内皮前体细胞功能障碍有关的疾病。还提供了低剂量促红细胞生成素在制备用于治疗此类疾病的药物组合物中的用途,并且还提供了这样的药物组合物,所述药物组合物包括:促红细胞生成素和其他合适的活性成分用于刺激内皮前体细胞。

版权:(C)2011,日本特许厅&INPIT

著录项

  • 公开/公告号JP2010235613A

    专利类型

  • 公开/公告日2010-10-21

    原文格式PDF

  • 申请/专利权人 EPOPLUS GMBH & CO KG;

    申请/专利号JP20100113592

  • 发明设计人 FERDINAND HERMANN BAHLMANN;HERMANN HALLER;

    申请日2010-05-17

  • 分类号A61K38/22;A61P17/16;A61P17/14;A61P17;A61K8/64;A61Q19;A61Q19/08;A61Q7;A61Q1;A61P43;A61P1/16;A61P19/08;A61P1/04;A61P13/12;A61P17/02;A61L27;

  • 国家 JP

  • 入库时间 2022-08-21 19:06:01

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号